Long-term outcomes from upgrade to cardiac resynchronisation therapy in ischaemic versus non-ischaemic heart disease

References

• Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7–11. doi: 10.15420/cfr.2016:25:2.
   PubMedGoogle Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975. doi: 10.1002/ejhf.592.
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787–1847.
   PubMed Web of Science ®Google Scholar
• Ruschitzka F, Abraham WT, Singh JP, et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med. 2013;369(15):1395–1405. doi: 10.1056/NEJMoa1306687.
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC) With the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599–3726. doi: 10.1093/eurheartj/ehab368.
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Bozkurt B, Aguilar D, et al. AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;145(18):e895–e1032.
   Google Scholar
• Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42(35):3427–3520. doi: 10.1093/eurheartj/ehab364.
   PubMed Web of Science ®Google Scholar
• Mittal S, Musat DL, Hoskins MH, et al. Clinical outcomes after ablation of the AV junction in patients with atrial fibrillation: impact of cardiac resynchronization therapy. J Am Heart Assoc. 2017;6(12). doi: 10.1161/JAHA.117.007270.
   Web of Science ®Google Scholar
• Lu W, Lin J, Dai Y, et al. The therapeutic effects of upgrade to cardiac resynchronization therapy in pacing-induced cardiomyopathy or chronic right ventricular pacing patients: a meta-analysis. Heart Fail Rev. 2022;27(2):507–516. doi: 10.1007/s10741-021-10091-z.
   PubMed Web of Science ®Google Scholar
• Merchant FM, Mittal S. Pacing induced cardiomyopathy. J Cardiovasc Electrophysiol. 2020;31(1):286–292. doi: 10.1111/jce.14277.
   PubMed Web of Science ®Google Scholar
• Jędrzejczyk-Patej E, Mazurek M, Kotalczyk A, et al. Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes. Europace. 2021;23(1):113–122. doi: 10.1093/europace/euaa339.
   PubMed Web of Science ®Google Scholar
• Rickard J, Michtalik H, Sharma R, et al. Predictors of response to cardiac resynchronization therapy: a systematic review. Int J Cardiol. 2016;225:345–352. doi: 10.1016/j.ijcard.2016.09.078.
   PubMed Web of Science ®Google Scholar
• Bogale N, Witte K, Priori S, et al. The european cardiac resynchronization therapy survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades. Eur J Heart Fail. 2011;13(9):974–983. doi: 10.1093/eurjhf/hfr085.
   PubMed Web of Science ®Google Scholar
• Cheung JW, Ip JE, Markowitz SM, et al. Trends and outcomes of cardiac resynchronization therapy upgrade procedures: a comparative analysis using a United States national database 2003-2013. Heart Rhythm. 2017;14(7):1043–1050. doi: 10.1016/j.hrthm.2017.02.017.
   PubMed Web of Science ®Google Scholar
• Nemer DM, Patel DR, Madden RA, et al. Comparative analysis of procedural outcomes and complications Between de novo and upgraded cardiac resynchronization therapy. JACC Clin Electrophysiol. 2021;7(1):62–72. doi: 10.1016/j.jacep.2020.07.022.
   PubMedGoogle Scholar
• Kosztin A, Vamos M, Aradi D, et al. De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis. Heart Fail Rev. 2018;23(1):15–26. doi: 10.1007/s10741-017-9652-1.
   PubMed Web of Science ®Google Scholar
• Linde CM, Normand C, Bogale N, et al. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II. Eur J Heart Fail. 2018;20(10):1457–1468. doi: 10.1002/ejhf.1235.
   PubMed Web of Science ®Google Scholar
• Vamos M, Erath JW, Bari Z, et al. Effects of upgrade versus de novo cardiac resynchronization therapy on clinical response and long-term survival: results from a multicenter study. Circ Arrhythmia Electrophysiol. 2017;10(2):e004471.
   PubMed Web of Science ®Google Scholar
• Beggs SAS, Jhund PS, Jackson CE, et al. Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis. Heart. 2018;104(2):144–150. doi: 10.1136/heartjnl-2016-310850.
   PubMed Web of Science ®Google Scholar
• Køber L, Thune JJ, Nielsen JC, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221–1230. doi: 10.1056/NEJMoa1608029.
   PubMed Web of Science ®Google Scholar
• Pocock SJ, Ariti CA, McMurray JJ, et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J. 2013;34(19):1404–1413. doi: 10.1093/eurheartj/ehs337.
   PubMed Web of Science ®Google Scholar
• Kirkfeldt RE, Johansen JB, Nohr EA, et al. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186–1194. doi: 10.1093/eurheartj/eht511.
   PubMed Web of Science ®Google Scholar
• Poole JE, Gleva MJ, Mela T, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122(16):1553–1561. doi: 10.1161/CIRCULATIONAHA.110.976076.
   PubMed Web of Science ®Google Scholar
• Scott PA, Whittaker A, Zeb M, et al. Rates of upgrade of ICD recipients to CRT in clinical practice and the potential impact of the more liberal use of CRT at initial implant. Pacing Clin Electrophysiol. 2012;35(1):73–80. doi: 10.1111/j.1540-8159.2011.03255.x.
   PubMed Web of Science ®Google Scholar
• Kosiuk J, Krause M, Doering M, et al. Outcome in patients undergoing upgrade to cardiac resynchronization therapy: predictors of outcome after upgrade to CRT. Heart Vessels. 2020;35(1):104–109. doi: 10.1007/s00380-019-01449-3.
   PubMed Web of Science ®Google Scholar
• Mullens W, Auricchio A, Martens P, et al. Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: a joint position statement from the heart failure association (HFA), european heart rhythm association (EHRA), and european association of cardiovascular imaging (EACVI) of the european society of cardiology. Eur J Heart Fail. 2020;22(12):2349–2369. doi: 10.1002/ejhf.2046.
   PubMed Web of Science ®Google Scholar
• Bart BA, Shaw LK, McCants CB, Jr., et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol. 1997;30(4):1002–1008. doi: 10.1016/s0735-1097(97)00235-0.
   PubMed Web of Science ®Google Scholar
• Singh B, Hsieh YC, Liu YB, et al. Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: sub-analysis of the multi-center improve SCA study. Indian Heart J. 2023;75(2):115–121. doi: 10.1016/j.ihj.2023.01.010.
   PubMedGoogle Scholar
• Rickard J, Cheng A, Spragg D, et al. QRS narrowing is associated with reverse remodeling in patients with chronic right ventricular pacing upgraded to cardiac resynchronization therapy. Heart Rhythm. 2013;10(1):55–60. doi: 10.1016/j.hrthm.2012.09.018.
   PubMed Web of Science ®Google Scholar
• Rath B, Willy K, Wolfes J, et al. Predictors of response to cardiac resynchronization therapy in patients with chronic right ventricular pacing. Clin Res Cardiol. 2021;110(6):877–883. doi: 10.1007/s00392-020-01785-9.
   PubMed Web of Science ®Google Scholar
• Codina P, Lupón J, Borrellas A, et al. Head-to-head comparison of contemporary heart failure risk scores. Eur J Heart Fail. 2021;23(12):2035–2044. doi: 10.1002/ejhf.2352.
   PubMed Web of Science ®Google Scholar
• Adelstein EC, Saba S. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J. 2007;153(1):105–112. doi: 10.1016/j.ahj.2006.10.015.
   PubMed Web of Science ®Google Scholar
• Kakouros N, Cokkinos DV. Right ventricular myocardial infarction: pathophysiology, diagnosis, and management. Postgrad Med J. 2010;86(1022):719–728. doi: 10.1136/pgmj.2010.103887.
   PubMed Web of Science ®Google Scholar
• Barsheshet A, Goldenberg I, Moss AJ, et al. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur Heart J. 2011;32(13):1622–1630. doi: 10.1093/eurheartj/ehq407.
   PubMed Web of Science ®Google Scholar
• Ghio S, Freemantle N, Scelsi L, et al. Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. Eur J Heart Fail. 2009;11(5):480–488. doi: 10.1093/eurjhf/hfp034.
   PubMed Web of Science ®Google Scholar
• Sadeghian H, Kazemisaied A, Rezvanfard M, et al. Improved right ventricular systolic function after cardiac resynchronization therapy in patients with heart failure. Tex Heart Inst J. 2022;49(5). doi: 10.14503/THIJ-20-7499.
   PubMed Web of Science ®Google Scholar
• St John Sutton M, Ghio S, Plappert T, et al. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York heart association class I/II heart failure. Circulation. 2009;120(19):1858–1865. doi: 10.1161/CIRCULATIONAHA.108.818724.
   PubMed Web of Science ®Google Scholar
• Merkely B, Kosztin A, Roka A, et al. Rationale and design of the BUDAPEST-CRT upgrade study: a prospective, randomized, multicentre clinical trial. Ep Europace. 2017;19(9):1549–1555.
   PubMed Web of Science ®Google Scholar